Causes and Risk Factors

Primary (idiopathic) thrombosis

In up to 30 % of cases no clear precipitating factor is identified. Researchers suspect subtle endothelial injury or undiagnosed hypercoagulable states.

Secondary causes

• Trauma or repetitive micro‑injury – sports (e.g., tennis, rowing), occupational vibrations, or a direct blow to the forearm.
• Atherosclerosis – plaque buildup narrows the lumen, predisposing to clot formation. Traditional cardiovascular risk factors (smoking, hypertension, diabetes, hyperlipidemia) apply.
• Embolic events – a clot that forms elsewhere (e.g., heart, proximal arteries) can travel downstream and lodge in the ulnar artery.
• Hypercoagulable disorders – Factor V Leiden, prothrombin gene mutation, antiphospholipid syndrome, cancer‑associated thrombosis, or use of oral contraceptives.
• Vasculitis – inflammatory conditions like Takayasu arteritis or systemic lupus erythematosus can damage the arterial wall.
• Arterial line or catheter placement – iatrogenic injury during medical procedures.

Risk factors

• Age > 50 years
• Male sex (approximately 1.5 × higher incidence)
• Smoking (dose‑dependent risk increase)
• Hypertension, diabetes, hyperlipidemia
• History of peripheral arterial disease
• Occupations involving repetitive forearm motion (e.g., mechanics, musicians)
• Known clotting disorders or prior thrombotic events

Diagnosis

Timely diagnosis relies on a combination of clinical assessment and imaging studies.

Physical examination

• Palpation of the ulnar pulse at the wrist.
• Assessment of skin color, temperature, and capillary refill.
• Allen’s test (or modified Allen’s test) to evaluate collateral flow from the radial artery.

Imaging and laboratory tests

• Doppler ultrasonography – first‑line, non‑invasive; shows reduced or absent flow in the ulnar artery and can locate the thrombus.
• CT angiography (CTA) – provides high‑resolution images of the arterial tree; useful for surgical planning.
• Magnetic resonance angiography (MRA) – an alternative when iodinated contrast is contraindicated.
• Conventional angiography – gold standard, performed when endovascular treatment is considered.
• Blood work – CBC, coagulation panel, lipid profile, inflammatory markers (CRP, ESR), and specific tests for hypercoagulable states if indicated.

Treatment Options

Treatment aims to restore perfusion, prevent clot propagation, and address underlying causes.

Medical Management

• Anticoagulation –
  • Heparin IV bolus followed by continuous infusion (target aPTT 1.5–2.5 × control) for acute cases.
  • Transition to oral anticoagulants (warfarin with INR 2–3, or direct oral anticoagulants such as apixaban 5 mg BID) for 3–6 months, depending on etiology.
• Antiplatelet therapy – aspirin 81‑325 mg daily; may be combined with clopidogrel 75 mg daily in cases with atherosclerotic disease.
• Pain control – NSAIDs or acetaminophen; avoid high‑dose NSAIDs if renal function is compromised.
• Risk‑factor modification – smoking cessation, blood pressure control, lipid‑lowering therapy (statins).

Endovascular Procedures

• Catheter‑directed thrombolysis – infusion of tissue plasminogen activator (tPA) directly into the clot; reserved for recent (< 14 days) occlusions and patients without high bleeding risk.
• Mechanical thrombectomy – specialized devices (e.g., aspiration catheters) can physically remove the clot; gaining popularity for upper‑extremity arteries.
• Percutaneous transluminal angioplasty (PTA) with stenting – used when underlying atherosclerotic stenosis is present.

Surgical Options

• Open thromboembolectomy – Fogarty balloon catheter is introduced through a small incision to extract the clot.
• Bypass grafting – autologous vein or synthetic graft placed to reroute blood around a non‑reconstructable segment.
• Endarterectomy – removal of plaque and thrombus from the arterial wall.

Choice of therapy depends on symptom severity, time since onset, patient comorbidities, and availability of expertise.

Living with Ulnar Artery Thrombosis

Daily Management Tips

• Medication adherence – take anticoagulants exactly as prescribed; set daily alarms.
• Monitor for signs of recurrence – note new pain, color change, or loss of pulse.
• Hand positioning – avoid prolonged compression of the wrist (e.g., tight straps, watchbands).
• Gentle exercise – low‑impact hand‑grip exercises improve collateral circulation without over‑loading the artery.
• Foot‑arm heel‑to‑toe check – compare temperature and capillary refill of both hands each morning.
• Regular follow‑up – vascular clinic visits every 3‑6 months initially, then annually if stable.

Impact on Work and Activities

If your occupation involves heavy manual labor or repetitive wrist motion, discuss ergonomic modifications with your employer or occupational therapist. Use padded gloves, take frequent micro‑breaks, and consider rotating tasks to lessen strain on the ulnar side of the forearm.

Prevention

• Control cardiovascular risk factors – maintain blood pressure < 130/80 mmHg, A1c < 7 % (if diabetic), LDL‑C < 70 mg/dL for high‑risk individuals.
• Quit smoking – nicotine replacement, counseling, or prescription meds (varenicline, bupropion).
• Exercise regularly – 150 min/week of moderate aerobic activity; include upper‑extremity flexibility stretches.
• Protect against trauma – wear protective gear during sports; use ergonomic tools.
• Screen for hypercoagulability if you have a personal/family history of clots; prophylactic anticoagulation may be indicated in selected cases.

Complications

If left untreated, ulnar artery thrombosis can lead to serious sequelae:

• Critical limb ischemia of the hand – persistent pain at rest, ulceration, or gangrene.
• Permanent nerve damage due to prolonged ischemia (e.g., ulnar neuropathy).
• Loss of hand function – decreased grip strength, impaired fine motor skills.
• Systemic embolization – rare, but clot fragments can travel to larger arteries.
• Re‑thrombosis – especially if risk factors are not addressed.

When to Seek Emergency Care

References

1. Mayo Clinic. “Peripheral artery disease.” Updated 2023. https://www.mayoclinic.org
2. Cleveland Clinic. “Upper Extremity Arterial Thromboembolic Disease.” 2022. https://my.clevelandclinic.org
3. J Vasc Surg. “Incidence and outcomes of upper‑extremity arterial occlusions.” 2019;69(4):1234‑1242.
4. American Heart Association. “Guidelines for the Management of Peripheral Arterial Disease.” 2022. https://www.aha.org
5. NIH National Library of Medicine. “Anticoagulation therapy for acute arterial thrombosis.” 2021. https://pubmed.ncbi.nlm.nih.gov
6. World Health Organization. “Global Report on Trends in Non‑communicable Disease Risk Factors.” 2023.